arrow
D

David B. Weiner

vaccine and immunotherapy center
H指数:92
被引数:3.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A complement modulated, broadly reactive anti-PhtD antibody improves potency and protection during Streptococcus pneumoniae infection

补体调节的、广泛反应性的抗PhtD抗体在肺炎链球菌感染期间增强了效力和保护作用

2026-08-240
OAAI
Multivalent DNA vaccines induce potent cellular responses and prolong BCG-mediated control of Mycobacterium tuberculosis

多价DNA疫苗诱导强效细胞免疫应答并延长BCG介导的对结核分枝杆菌的控制

2026-07-140
PRE
Engineering single-dose plasmid DNA for sustained in vivo delivery of designer incretins

单剂量质粒DNA的工程设计以实现体内长效递送定制型肠促胰岛素

2026-06-190
OA
Rapid elicitation of neutralizing Asn332-glycan-independent antibodies to the V3-glycan epitope of HIV-1 Env in nonhuman primates

在非人灵长类动物中快速激发针对HIV-1 Env V3-glycan表位的中和Asn332-glycan-independent抗体

2026-02-030
OAAI
Long-Term Implementation of a Multi-Disciplinary Trial of Void Algorithm Reduces Catheter-Associated Urinary Tract Infections on Surgical Step-Down Unit

多学科团队实施的“导尿管排空算法”长期应用可减少外科降级病房的导尿管相关尿路感染发生率

2025-12-010
PRE
Synthetic DNA co-immunization with vaccine-aligned common consensus nucleoprotein and hemagglutinin protects mice against lethal influenza infection with a single immunization

合成DNA与与疫苗同源的通用共同核蛋白和血凝素共免疫,单次免疫即可保护小鼠免受致死性流感感染

2025-11-260
OAAI
Electroporation and LNP-mediated delivery of plasmid DNA-encoded H5N1 influenza virus hemagglutinin support protection against highly pathogenic avian influenza

电穿孔和LNP介导的质粒DNA编码的H5N1流感病毒血凝素递送支持对高致病性禽流感的保护

2025-11-220
OAAI
Safety and pharmacokinetics of SARS-CoV-2 DNA-encoded monoclonal antibodies in healthy adults: a phase 1 trial

SARS-CoV-2 DNA编码单克隆抗体的安全性与药代动力学:一项1期临床试验

2025-10-210
OAAI
Fc-modification of anti-PcrV gene-encoded antibodies modulates complement-mediated killing of Pseudomonas aeruginosa

Fc修饰的抗PcrV基因编码抗体调节铜绿假单胞菌的补体介导杀伤

2025-08-020
OA
Convergence and divergence of B cell responses in two HIV-1 Env immunizations in Rhesus macaques

恒河猴中两次HIV-1 Env免疫的B细胞反应的收敛与发散

2025-05-150
OA
DNA immunotherapy for recurrent respiratory papillomatosis (RRP): phase 1/2 study assessing efficacy, safety, and immunogenicity of INO-3107

DNA免疫疗法治疗复发性呼吸道乳头状瘤病(RRP):评估INO-3107疗效、安全性和免疫原性的1/2期研究

2025-02-120
OA
Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteers

低剂量或单剂量疫苗应用优化的自复制RNA平台的安全性与免疫原性:一项在健康志愿者中进行的随机、开放标签I期研究

2025-01-074
OA